Taurolidine-induced Severe Anaphylaxis
- PMID: 41050135
- PMCID: PMC12495460
- DOI: 10.1016/j.xkme.2025.101086
Taurolidine-induced Severe Anaphylaxis
Abstract
Taurolidine-based catheter lock solutions are widely used for central venous catheters. Although minor infusion-related symptoms and allergic reactions have been documented, no systemic effects or severe cases of anaphylaxis have been observed. Here, we detail a case of taurolidine-induced life-threatening anaphylaxis. We report the case of a 59-year-old man who had a severe anaphylactic reaction to taurolidine following accidental intravenous infusion, which required treatment in the intensive care unit. Anaphylactic shock, which was resistant to conventional treatment with epinephrine, required additional management with norepinephrine and vasopressin. After the resolution of the anaphylactic episode, the patient was discharged from the intensive care unit. An outpatient allergy work-up using a skin prick test was performed, which confirmed a suspected allergy to taurolidine. In conclusion, taurolidine induced a severe, prolonged anaphylactic shock that did not respond to conventional treatment with intravenous and inhaled epinephrine, antihistamines, glucocorticoids, or continuous norepinephrine infusion. New treatment strategies for refractory anaphylactic shock are needed.
Keywords: Allergic reaction; allergy; catheter lock solution; epinephrine; shock.
© 2025 The Authors.
Figures
References
-
- Winnicki W., Herkner H., Lorenz M., et al. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney Int. 2018;93(3):753–760. - PubMed
-
- Al-Ali F., Hamdy A.F., Hamad A., et al. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. Nephrol Dial Transplant. 2018;33(4):619–626. - PubMed
-
- Korzilius J.W., Gillis V.E.L.M., Wouters Y., Wanten G.J.A. Taurolidine-related adverse events in patients on home parenteral nutrition frequently indicate catheter-related problems. Clin Nutr. 2022;41(10):2178–2184. - PubMed
-
- Tsuda A., Tanaka K.A., Huraux C., Szlam F., Sato N., Yamaguchi K., Levy J.H. The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. Anesth Analg. 2001;93(6):1453–14539. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
